SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-14-000934
Filing Date
2014-03-20
Accepted
2014-03-20 16:56:55
Documents
12
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K abio-10k_20131231.htm 10-K 3443923
2 EX-10.65 abio-ex10_20131231551.htm EX-10 168367
3 EX-23.1 abio-ex23_2013123111.htm EX-23 4442
4 EX-31.1 abio-ex31_2013123112.htm EX-31 14299
5 EX-31.2 abio-ex31_2013123113.htm EX-31 15763
6 EX-32.1 abio-ex32_2013123114.htm EX-32 10450
  Complete submission text file 0001564590-14-000934.txt   11289132

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT abio-20131231.xml EX-101.INS 1366284
8 XBRL TAXONOMY EXTENSION SCHEMA abio-20131231.xsd EX-101.SCH 57590
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20131231_cal.xml EX-101.CAL 53385
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20131231_def.xml EX-101.DEF 339075
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20131231_lab.xml EX-101.LAB 468707
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20131231_pre.xml EX-101.PRE 394825
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22873 | Film No.: 14707288
SIC: 2835 In Vitro & In Vivo Diagnostic Substances